New Delhi: Aurobindo Pharma today reported a consolidated net profit at Rs 535 crore for the third quarter ended December 31, 2015.
The company had posted a consolidated net profit of Rs 384 crore in the same period last fiscal, Aurobindo Pharma said in a BSE filing.
Net sales during the period under review stood at Rs 3,432.08 crore. In the corresponding period previous fiscal, the sales were Rs 3,142.46 crore, it added.
During the previous year on December 4, 2014 the company’s US arm Aurobindo Pharma USA Inc had acquired Natrol LLC. The above consolidated results include that of Natrol and therefore the corresponding figures are not comparable, Aurobindo said.
The board of the company has approved third interim dividend of 70 per cent at 70 paisa for every share of face value Re 1 for the year 2015-16, it added.
Shares of Aurobindo Pharma ended the day at Rs 743.30 apiece, down 0.43 per cent from the previous close on the BSE.